Functional Importance of the Noradrenaline System in connection with Memory Impairments and Alzheimer's Disease

Background and aims

Noradrenaline is a neurotransmitter. The brain synthesizes all of its noradrenaline in the locus coeruleus, a small nucleus in the brainstem. It is known that this nucleus is affected early on in the onset of Alzheimer's disease. Little is known, however, about how this relationship affects the symptoms and the course of the disease.

Findings obtained from study of this relationship could conceivably lead to treatment strategies that specifically target the noradrenaline system.

Course of the study

Study participants with mild Alzheimer's dementia, and patients with slight memory impairments, will be examined via magnetic resonance imaging (MRI), electroencephalography (EEG) and measurement of pupil width.

A full set of information about the study can be downloaded here (in German only): Flyer

Principle Investigator: PD Dr. Klaus Fließbach
Start of the study: 2013
Status: mono centric (DZNE Bonn), ongoing, recruiting active

Study Coordination / Project Management

Priv.-Doz. Dr. Dipl.-Psych. Klaus Fließbach
klaus.fliessbach@ukb.uni-bonn.de
 +49 228 287-15717
 +49 228 287-19419
M. Sc. Verena Kiven
verena.kiven@dzne.de
 +49 228 43302-873
 +49 228 43302-812

Info-Hotline

Thursdays 1:30-4:30 pm

Patients +49 800-7799001

(free of charge)

Professionals +49 180-779900

(9 Cent/Min. German landline, mobile and out of Germany possibly more expensive)

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: